摘要
Hepatocellular carcinoma (HCC) is among the most usual cancers globally. In China, Biejiajian pill (BJJP), Traditional Chinese Medicine clinical prescription, is broadly utilized for the prevention and therapy of HCC. However, the mechanisms by which BJJP exerts its effects on the prevention of tumor invasion and metastasis are still largely unknown. In this study, in vitro multiple hepatic cancer cell lines and an in vivo xenograft mice model were used to validate the preventive effects and molecular mechanisms of BJJP in HCC. We established that BJJP significantly repressed the proliferation, metastasis and infiltration of HCC cells. Furthermore, BJJP remarkably suppressed HCC cell migration, as well as invasion via epithelial-mesenchymal transition (EMT) by modulating Snail expression, which was associated with the repression of Akt/GSK-3 beta/Snail signaling axis activation. In vivo HCC xenograft results indicated that BJJP delayed HCC development and efficiently inhibited lung metastasis. Taken together, BJJP was shown to be an effective therapeutic agent against HCC through repression of the Akt/GSK-3 beta/Snail signaling cascade and EMT.
学科与关键词
- Biejiajian pill inhibits progression of hepatocellular carcinoma by downregulating PDGFRO signaling in cancer-associated fibroblastsChen, Weicong; Yang, Xuemei; Sun, Jialing; Chen, Yuyao; Zhao, Wenting; He, Chunyu; An, Haiyan; Pang, Jie; Xu, Wei; Wen, Bin*; Sun, Haitao*; He, Songqi*Journal of Ethnopharmacology, 2023, 301: 115825.被引 1
- Biejiajian Pill Promotes the Infiltration of CD8+ T Cells in Hepatocellular Carcinoma by Regulating the Expression of CCL5Yang, Xuemei; Sun, Jialing; Wen, Bin; Wang, Yu; Zhang, Mingjia; Chen, Weicong; Zhao, Wenting; He, Chunyu; Zhong, Xiaodan; Liu, Yang; Li, Tong; Sun, Haitao*; He, Songqi*Frontiers in Pharmacology, 2021, 12: 771046.被引 4
- Traditional Chinese medicine formulation Yanggan Jiedu Sanjie inhibits TGF-β1-induced epithelial-mesenchymal transition and metastatic potential in human hepatocarcinoma Bel-7402 cells.Hu, Bing*; An, Hong-Mei; Yan, Xia; Zheng, Jia-Lu; Huang, Xiao-Wei; Li, MiaoBMC Complement Altern Med, 2019, 19(1): 67.
